Australian biotech PYC Therapeutics (ASX:PYC) has taken a major step forward with its lead program, presenting clinical data that signals a significant opportunity in the treatment of genetic eye diseases — a space where no treatments currently exist. The company announced that interim results from its Phase 1/2 trials for VP-001 — a drug candidate
Read More
Australia’s Push To Lead In High Purity Alumina (HPA) Impact Minerals (ASX:IPT) has secured a 50% stake in Alluminous Pty Ltd, which recently acquired the high-potential HiPurA® HPA processing technology. The move is a step in Impact’s strategy to become a vertically integrated HPA producer and could shave years off its path to commercialisation. “This
Read More
Equity Story Group Taps Booming Advisory Sector Equity Story Group Ltd (ASX:EQS) has taken a major step into full-service wealth management, signing a binding agreement to acquire long-standing financial advisory firm Baker Young Limited. The strategic acquisition aims to expand Equity Story’s footprint into retail stockbroking and corporate advisory—two segments showing significant growth amid increasing
Read More
Independent Resource Estimate Highlights Massive Oil Exploration Upside A new independent assessment has confirmed a best estimate of 3 billion barrels of oil across five high-impact exploration prospects offshore northern Peru — putting Condor Energy (ASX:CND) firmly on the radar of investors seeking exposure to large-scale frontier oil opportunities. “The independent resource estimate … validates
Read More
Federal Funding Unlocks New Health Access Opportunity Atomo Diagnostics (ASX:AT1) has received a $230,000 order from Thorne Harbour Health (THH) to support the national rollout of its HIV self-test kits through public-funded vending machines. The initiative is part of the Federal Government’s CONNECT Programme, announced in the May 2024 Budget, and signals a shift toward
Read More
Funding Injection Strengthens Spenda’s Push Towards Operational Break-Even Spenda Limited (ASX:SPX) has executed a $3 million term loan facility with Capricorn Society Limited. The facility bolsters Spenda’s financial position and signals confidence in its strategic direction, The facility’s flexible funding arrangement is designed to support the company’s capital expenditure and working capital requirements as it
Read More
Cannabinoid Therapy Gains Foothold in Germany’s Epilepsy Market Argent BioPharma (ASX:RGT) has secured approval for its flagship cannabinoid-based epilepsy treatment, CannEpil™, to be prescribed in Germany. This milestone marks a major step in the company’s European expansion and strengthens its presence in one of the region’s key pharmaceutical markets. Germany has approximately 816,000 epilepsy patients,
Read More
Enmore Gold Project Shows Exploration Potential Koonenberry Gold (ASX:KNB) has returned high-grade gold intercepts from its first diamond drillhole at the Enmore Gold Project in northeast New South Wales. The results validate historical drill data and highlight the potential for a significant mineralised system. Managing Director Dan Power described the outcome as “a truly exciting
Read More
Property Market Shift Opens Opportunities Australia’s property sector continues to attract strong investor interest, with major players eyeing strategic acquisitions. AVJennings Limited (ASX:AVJ) has now entered into a Scheme Implementation Deed (SID) with AVID Property Group, in partnership with Proprium Capital Partners, in a deal valued at $0.655 per share. This agreement provides a significant
Read More
The RBA’s benchmark interest rate was left unchanged at 4.10% at the Bank’s 31 March-1 April Board meeting, with our central bank deciding to leave well enough alone ahead of a swag of political and economic uncertainties hitting markets over coming weeks. This left the RBA rate a touch under the existing US Fed Funds
Read More
